Epstein–Barr virus (EBV)-associated gastric cancer (GC) accounts for about 9% of GC patients, but its pathogenesis remains unclear. Glutathione peroxidase 4 (GPX4) is an important antioxidant enzyme that is highly expressed in various tumors and is associated with viral infections. This study aimed to clarify the relationship between EBV and GPX4 and the role of GPX4 in the occurrence and development of EBV-associated GC.
Results:
EBV infection leads to oxidative stress and excessive generation of reactive oxygen species (ROS) in GC cells. At the same time, EBV upregulates the expression of antioxidant enzyme GPX4 through the latent membrane protein 2A (LMP2A)/p62/Kelch-like ECH-associated protein 1(Keap1)/nuclear factor (erythroid-derived 2)-like 2 (NRF2) axis, eliminating excessive ROS to balance redox homeostasis and maintain its own survival. The high expression of GPX4 in GC inhibits EBV’s immediate early lytic gene BZLF1 expression, thereby inhibiting EBV reactivation, and promotes cell migration and proliferation by upregulating lipocalin-2 (LCN2).
Innovation:
This study is the first to demonstrate that EBV-induced GPX4 expression via the LMP2A/p62/Keap1/NRF2 axis contributes to both viral latency and tumor progression in GC.
Conclusion:
EBV activates the p62/Keap1/NRF2 signaling pathway through LMP2A to upregulate the expression of GPX4, thereby alleviating oxidative stress caused by viral infection and maintaining the redox homeostasis in GC cells. Such enhanced expression not only maintains the latent infection of EBV but also promotes the malignant transformation of GC cells through LCN2. Antioxid. Redox Signal. 44, 85–102.
BaoG, CliftonM, HoetteTM, et al.Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol, 2010; 6(8):602–609; doi: 10.1038/nchembio.402
2.
BonnerMY, ArbiserJL. The antioxidant paradox: What are antioxidants and how should they be used in a therapeutic context for cancer. Future Med Chem, 2014; 6(12):1413–1422; doi: 10.4155/fmc.14.86
3.
BraultC, LévyP, DuponchelS, et al.Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity. Gut, 2016; 65(1):144–154; doi: 10.1136/gutjnl-2014-307904
4.
BrayF, FerlayJ, SoerjomataramI, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018; 68(6):394–424; doi: 10.3322/caac.21492
BurtonEM, VoyerJ, GewurzBE. Epstein-Barr virus latency programs dynamically sensitize B cells to ferroptosis. Proc Natl Acad Sci U S A, 2022; 119(11):e2118300119; doi: 10.1073/pnas.2118300119
7.
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 2014; 513(7517):202–209; doi: 10.1038/nature13480
8.
ChengL, HeQ, LiuB, et al.SGK2 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating GPX4. Cell Death Dis, 2023; 14(1):74; doi: 10.1038/s41419-023-05614-5
9.
CohenJI, FauciAS, VarmusH, et al.Epstein-Barr virus: An important vaccine target for cancer prevention. Sci Transl Med, 2011; 3(107):107fs7; doi: 10.1126/scitranslmed.3002878
10.
DodsonM, Castro-PortuguezR, ZhangDD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol, 2019; 23:101107; doi: 10.1016/j.redox.2019.101107
11.
GaladariS, RahmanA, PallichankandyS, et al.Reactive oxygen species and cancer paradox: To promote or to suppress? Free Radic Biol Med, 2017; 104:144–164; doi: 10.1016/j.freeradbiomed.2017.01.004
12.
GargouriB, NasrR, Ben MansourR, et al.Reactive oxygen species production and antioxidant enzyme expression after Epstein-Barr virus lytic cycle induction in Raji cell line. Biol Trace Elem Res, 2011; 144(1–3):1449–1457; doi: 10.1007/s12011-011-9148-9
13.
Gilardini MontaniMS, TarquiniG, SantarelliR, et al.p62/SQSTM1 promotes mitophagy and activates the NRF2-mediated antioxidant and anti-inflammatory response restraining EBV-driven B lymphocyte proliferation. Carcinogenesis, 2022; 43(3):277–287; doi: 10.1093/carcin/bgab116
14.
GorriniC, HarrisIS, MakTW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov, 2013; 12(12):931–947; doi: 10.1038/nrd4002
15.
GruhneB, SompallaeR, MarescottiD, et al.The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci U S A, 2009; 106(7):2313–2318; doi: 10.1073/pnas.0810619106
16.
GuoR, GewurzBE. Epigenetic control of the Epstein-Barr lifecycle. Curr Opin Virol, 2022; 52:78–88; doi: 10.1016/j.coviro.2021.11.013
17.
HuJ, LiY, LiH, et al.Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy. Theranostics, 2020; 10(26):11921–11937; doi: 10.7150/thno.46006
18.
ImaiS, KoizumiS, SugiuraM, et al.Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A, 1994; 91(19):9131–9135; doi: 10.1073/pnas.91.19.9131
19.
IqbalMJ, KabeerA, AbbasZ, et al.Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Commun Signal, 2024; 22(1):7; doi: 10.1186/s12964-023-01398-5
20.
IvanovAV, Valuev-EllistonVT, IvanovaON, et al.Oxidative stress during HIV infection: Mechanisms and consequences. Oxid Med Cell Longev, 2016; 2016:8910396; doi: 10.1155/2016/8910396
21.
KenneySC, MertzJE. Regulation of the latent-lytic switch in Epstein-Barr virus. Semin Cancer Biol, 2014; 26:60–68; doi: 10.1016/j.semcancer.2014.01.002
22.
KimSL, LeeST, MinIS, et al.Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer. Cancer Sci, 2017a;108(11):2176–2186; doi: 10.1111/cas.13389
23.
KimSM, HurDY, HongSW, et al.EBV-encoded EBNA1 regulates cell viability by modulating miR34a-NOX2-ROS signaling in gastric cancer cells. Biochem Biophys Res Commun, 2017b;494(3–4):550–555; doi: 10.1016/j.bbrc.2017.10.095
24.
KomatsuM, KurokawaH, WaguriS, et al.The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol, 2010; 12(3):213–223; doi: 10.1038/ncb2021
25.
KrausRJ, CordesBA, SathiamoorthiS, et al.Reactivation of Epstein-Barr virus by HIF-1α requires p53. J Virol, 2020; 94(18):e00722-20; doi: 10.1128/JVI.00722-20
26.
LassouedS, GargouriB, El Feki AelF, et al.Transcription of the Epstein-Barr virus lytic cycle activator BZLF-1 during oxidative stress induction. Biol Trace Elem Res, 2010; 137(1):13–22; doi: 10.1007/s12011-009-8553-4
27.
LeeHJ, LeeEK, LeeKJ, et al.Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer, 2006; 118(10):2490–2497; doi: 10.1002/ijc.21657
28.
LiFJ, LongHZ, ZhouZW, et al.System X(c) (-)/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol, 2022; 13:910292; doi: 10.3389/fphar.2022.910292
29.
LiH, LiuS, HuJ, et al.Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis. Int J Biol Sci, 2016; 12(11):1309–1318; doi: 10.7150/ijbs.16552
30.
MaQ. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol, 2013; 53:401–426; doi: 10.1146/annurev-pharmtox-011112-140320
31.
MaQ, CavallinLE, LeungHJ, et al.A role for virally induced reactive oxygen species in Kaposi’s sarcoma herpesvirus tumorigenesis. Antioxid Redox Signal, 2013; 18(1):80–90; doi: 10.1089/ars.2012.4584
32.
MaSD, HegdeS, YoungKH, et al.A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol, 2011; 85(1):165–177; doi: 10.1128/JVI.01512-10
33.
MaT, DuJ, ZhangY, et al.GPX4-independent ferroptosis-a new strategy in disease’s therapy. Cell Death Discov, 2022; 8(1):434; doi: 10.1038/s41420-022-01212-0
34.
MarraM, SordelliIM, LombardiA, et al.Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: An overview. J Transl Med, 2011; 9:171; doi: 10.1186/1479-5876-9-171
35.
MathewSS, BryantPW, BurchAD. Accumulation of oxidized proteins in Herpesvirus infected cells. Free Radic Biol Med, 2010; 49(3):383–391; doi: 10.1016/j.freeradbiomed.2010.04.026
36.
MurataT, NaritaY, SugimotoA, et al.Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency. J Virol, 2013; 87(18):10148–10162; doi: 10.1128/JVI.01002-13
37.
MurataT, SugimotoA, InagakiT, et al.Molecular basis of Epstein-Barr Virus latency establishment and lytic reactivation. Viruses, 2021; 13(12):2344; doi: 10.3390/v13122344
38.
MurataT, TsurumiT. Switching of EBV cycles between latent and lytic states. Rev Med Virol, 2014; 24(3):142–153; doi: 10.1002/rmv.1780
39.
Perez-RiverolY, BaiJ, BandlaC, et al.The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res, 2022; 50(D1):D543–D552; doi: 10.1093/nar/gkab1038
40.
RayPD, HuangBW, TsujiY. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal, 2012; 24(5):981–990; doi: 10.1016/j.cellsig.2012.01.008
41.
RosemarieQ, SugdenB. Epstein-Barr virus: How its lytic phase contributes to oncogenesis. Microorganisms, 2020; 8(11):1824; doi: 10.3390/microorganisms8111824
42.
Santiago-SánchezGS, Pita-GrisantiV, Quiñones-DíazB, et al.Biological functions and therapeutic potential of Lipocalin 2 in cancer. Int J Mol Sci, 2020; 21(12):4365; doi: 10.3390/ijms21124365
SeibtTM, PronethB, ConradM. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med, 2019; 133:144–152; doi: 10.1016/j.freeradbiomed.2018.09.014
45.
ShiibaM, SaitoK, FushimiK, et al.Lipocalin-2 is associated with radioresistance in oral cancer and lung cancer cells. Int J Oncol, 2013; 42(4):1197–1204; doi: 10.3892/ijo.2013.1815
46.
SuY, ZhaoB, ZhouL, et al.Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett, 2020; 483:127–136; doi: 10.1016/j.canlet.2020.02.015
47.
SunCC, Thorley-LawsonDA. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol, 2007; 81(24):13566–13577; doi: 10.1128/JVI.01055-07
48.
TorneAS, RobertsonES. Epigenetic mechanisms in latent Epstein-Barr virus infection and associated cancers. Cancers (Basel), 2024; 16(5):991; doi: 10.3390/cancers16050991
49.
UrsiniF, MaiorinoM. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med, 2020; 152:175–185; doi: 10.1016/j.freeradbiomed.2020.02.027
50.
VasquezM, ZunigaM, RodriguezA. Oxidative stress and pathogenesis in malaria. Front Cell Infect Microbiol, 2021; 11:768182; doi: 10.3389/fcimb.2021.768182
51.
WangQ, BinC, XueQ, et al.GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis. Cell Death Dis, 2021; 12(5):426; doi: 10.1038/s41419-021-03718-4
52.
WangYP, YuGR, LeeMJ, et al.Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Hepatology, 2013; 58(4):1349–1361; doi: 10.1002/hep.26467
53.
WeinbergF, RamnathN, NagrathD. Reactive oxygen species in the tumor microenvironment: An overview. Cancers (Basel), 2019; 11(8):1191; doi: 10.3390/cancers11081191
54.
XieY, KangR, KlionskyDJ, et al.GPX4 in cell death, autophagy, and disease. Autophagy, 2023; 19(10):2621–2638; doi: 10.1080/15548627.2023.2218764
55.
XuM, ZhangWL, ZhuQ, et al.Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies. Theranostics, 2019; 9(4):1115–1124; doi: 10.7150/thno.29622
56.
YangJ, LiuZ, ZengB, et al.Epstein-Barr virus-associated gastric cancer: A distinct subtype. Cancer Lett, 2020; 495:191–199; doi: 10.1016/j.canlet.2020.09.019
57.
YuanL, LiS, ChenQ, et al.EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma. Cell Death Differ, 2022; 29(8):1513–1527; doi: 10.1038/s41418-022-00939-8
58.
YunSM, KimYS, HurDY. LMP1 and 2A induce the expression of Nrf2 Through Akt signaling pathway in Epstein-Barr Virus-Transformed B cells. Transl Oncol, 2019; 12(5):775–783; doi: 10.1016/j.tranon.2019.02.006
59.
ZhangY, ShiD, ZhangX, et al.Downregulation of MUS81 expression inhibits cell migration and maintains EBV latent infection through miR-BART9-5p in EBV-associated gastric cancer. J Med Virol, 2023; 95(4):e28725; doi: 10.1002/jmv.28725
60.
ZhangY, SwandaRV, NieL, et al.mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun, 2021; 12(1):1589; doi: 10.1038/s41467-021-21841-w
61.
ZhangY, WuY, DingB, et al.TNF-α inhibits Epstein Barr virus reactivation through the GPX4 mediated glutathione pathway. Sci Rep, 2025; 15(1):16448; doi: 10.1038/s41598-025-98679-5
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
